As of 2025-07-14, the Fair Value of Briacell Therapeutics Corp (BCT.TO) is -9.98 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.79 CAD, the upside of Briacell Therapeutics Corp is -457.54%.
With the market price of 2.79 CAD and our fair value calculation, Briacell Therapeutics Corp (BCT.TO) is not a good investment. Investing in BCT.TO stocks now will result in a potential loss of 457.54%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-07-31 | 2021-07-31 | 2022-07-31 | 2023-07-31 | 2024-07-31 | 5Y Avg | |
| Net income | -3.64 | -13.82 | -26.84 | -20.30 | -4.79 | -13.88 |
| YoY growth | 13.74% | -279.76% | -94.26% | 24.35% | 76.40% | -51.90% |
| Market Cap (mil) | 27.17 |
| P/E | |
| Forward P/E |
| EPS | -2.00 |
| Avg earnings growth rate | -51.90% |
| TTM earnings | -19.43 |